seed
Stage
2
Investors
About
Neurocess develops non-invasive brain-computer interface (BCI) technology that enables users to control devices and applications via brain signals.
Explore Neurocess's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.